Literature DB >> 27225478

DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling.

Ruijie Liu1, Jop H van Berlo1, Allen J York1, Ronald J Vagnozzi1, Marjorie Maillet1, Jeffery D Molkentin2.   

Abstract

RATIONALE: Mitogen-activated protein kinase (MAPK) signaling regulates the growth response of the adult myocardium in response to increased cardiac workload or pathological insults. The dual-specificity phosphatases (DUSPs) are critical effectors, which dephosphorylate the MAPKs to control the basal tone, amplitude, and duration of MAPK signaling.
OBJECTIVE: To examine DUSP8 as a regulator of MAPK signaling in the heart and its impact on ventricular and cardiac myocyte growth dynamics. METHODS AND
RESULTS: Dusp8 gene-deleted mice and transgenic mice with inducible expression of DUSP8 in the heart were used here to investigate how this MAPK-phosphatase might regulate intracellular signaling and cardiac growth dynamics in vivo. Dusp8 gene-deleted mice were mildly hypercontractile at baseline with a cardiac phenotype of concentric ventricular remodeling, which protected them from progressing towards heart failure in 2 surgery-induced disease models. Cardiac-specific overexpression of DUSP8 produced spontaneous eccentric remodeling and ventricular dilation with heart failure. At the cellular level, adult cardiac myocytes from Dusp8 gene-deleted mice were thicker and shorter, whereas DUSP8 overexpression promoted cardiac myocyte lengthening with a loss of thickness. Mechanistically, activation of extracellular signal-regulated kinases 1/2 were selectively increased in Dusp8 gene-deleted hearts at baseline and following acute pathological stress stimulation, whereas p38 MAPK and c-Jun N-terminal kinases were mostly unaffected.
CONCLUSIONS: These results indicate that DUSP8 controls basal and acute stress-induced extracellular signal-regulated kinases 1/2 signaling in adult cardiac myocytes that then alters the length-width growth dynamics of individual cardiac myocytes, which further alters contractility, ventricular remodeling, and disease susceptibility.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  dilated cardiomyopathy; disease susceptibility; dual-specificity phosphatase; heart failure; myocardium

Mesh:

Substances:

Year:  2016        PMID: 27225478      PMCID: PMC4938738          DOI: 10.1161/CIRCRESAHA.115.308238

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.

Authors:  H W Lim; L New; J Han; J D Molkentin
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

2.  Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo.

Authors:  Robert A Kaiser; Qiangrong Liang; Orlando Bueno; Yuan Huang; Troy Lackey; Raisa Klevitsky; Timothy E Hewett; Jeffery D Molkentin
Journal:  J Biol Chem       Date:  2005-07-25       Impact factor: 5.157

3.  Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.

Authors:  Li Li; Dong Fan; Cheng Wang; Jin-Yu Wang; Xiao-Bing Cui; Dan Wu; Yun Zhou; Li-Ling Wu
Journal:  Cardiovasc Res       Date:  2011-03-02       Impact factor: 10.787

4.  Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.

Authors:  Eugénie Goupil; Veronica Wisehart; Etienne Khoury; Brandon Zimmerman; Sahar Jaffal; Terence E Hébert; Stéphane A Laporte
Journal:  Mol Endocrinol       Date:  2012-05-25

5.  p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

Authors:  Kazuhiko Nishida; Osamu Yamaguchi; Shinichi Hirotani; Shungo Hikoso; Yoshiharu Higuchi; Tetsuya Watanabe; Toshihiro Takeda; Soh Osuka; Takashi Morita; Gen Kondoh; Yoshihiro Uno; Kazunori Kashiwase; Masayuki Taniike; Atsuko Nakai; Yasushi Matsumura; Jun-ichi Miyazaki; Tatsuhiko Sudo; Kenichi Hongo; Yoichiro Kusakari; Satoshi Kurihara; Kenneth R Chien; Junji Takeda; Masatsugu Hori; Kinya Otsu
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 6.  Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes.

Authors:  Konstantin Salojin; Tamas Oravecz
Journal:  J Leukoc Biol       Date:  2007-02-08       Impact factor: 4.962

7.  Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Authors:  Julian C Braz; Orlando F Bueno; Qiangrong Liang; Benjamin J Wilkins; Yan-Shan Dai; Stephanie Parsons; Joseph Braunwart; Betty J Glascock; Raisa Klevitsky; Thomas F Kimball; Timothy E Hewett; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

8.  MAP kinase phosphatase-3 (MKP-3) is transcriptionally and post-translationally up-regulated by hCG and modulates cAMP-induced p21 expression in MA-10 Leydig cells.

Authors:  Mercedes Mori Sequeiros García; Natalia V Gómez; Alejandra Gorostizaga; Andrea Acquier; Silvia I González-Calvar; Carlos F Mendez; Cristina Paz
Journal:  Mol Cell Endocrinol       Date:  2012-12-20       Impact factor: 4.102

9.  DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility.

Authors:  Marjorie Maillet; Nicole H Purcell; Michelle A Sargent; Allen J York; Orlando F Bueno; Jeffery D Molkentin
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

10.  DUSPs, to MAP kinases and beyond.

Authors:  Ching-Yu Huang; Tse-Hua Tan
Journal:  Cell Biosci       Date:  2012-07-09       Impact factor: 7.133

View more
  29 in total

1.  Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies.

Authors:  Anand P Singh; Michael S Glennon; Prachi Umbarkar; Manisha Gupte; Cristi L Galindo; Qinkun Zhang; Thomas Force; Jason R Becker; Hind Lal
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

2.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

3.  Dual Specific Phosphatase 7 Exacerbates Dilated Cardiomyopathy, Heart Failure, and Cardiac Death by Inactivating the ERK1/2 Signaling Pathway.

Authors:  Jing Liu; Yihen Yin; Jing Ni; Peiyu Zhang; Wei-Ming Li; Zheng Liu
Journal:  J Cardiovasc Transl Res       Date:  2022-05-20       Impact factor: 4.132

Review 4.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

5.  Ethyl pyruvate inhibits LPS induced IPEC-J2 inflammation and apoptosis through p38 and ERK1/2 pathways.

Authors:  Na Dong; Xinyao Xu; Chenyu Xue; Chensi Wang; Xinran Li; Chongpeng Bi; Anshan Shan
Journal:  Cell Cycle       Date:  2019-09-01       Impact factor: 4.534

6.  Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury.

Authors:  Y Yun; J Oh; Y Kim; G Kim; M Lee; Y Ha
Journal:  Gene Ther       Date:  2017-11-20       Impact factor: 5.250

7.  Microfibrillar-Associated Protein 4 Regulates Stress-Induced Cardiac Remodeling.

Authors:  Lisa E Dorn; William Lawrence; Jennifer M Petrosino; Xianyao Xu; Thomas J Hund; Bryan A Whitson; Matthew S Stratton; Paul M L Janssen; Peter J Mohler; Anders Schlosser; Grith L Sorensen; Federica Accornero
Journal:  Circ Res       Date:  2021-02-03       Impact factor: 17.367

8.  Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure.

Authors:  Duane D Hall; Jessica M Ponce; Biyi Chen; Kathryn M Spitler; Adrianne Alexia; Gavin Y Oudit; Long-Sheng Song; Chad E Grueter
Journal:  JCI Insight       Date:  2017-08-03

9.  Type 2 diabetes risk gene Dusp8 regulates hypothalamic Jnk signaling and insulin sensitivity.

Authors:  Sonja C Schriever; Dhiraj G Kabra; Katrin Pfuhlmann; Peter Baumann; Emily V Baumgart; Joachim Nagler; Fabian Seebacher; Luke Harrison; Martin Irmler; Stephanie Kullmann; Felipe Corrêa-da-Silva; Florian Giesert; Ruchi Jain; Hannah Schug; Julien Castel; Sarah Martinez; Moya Wu; Hans-Ulrich Häring; Martin Hrabe de Angelis; Johannes Beckers; Timo D Müller; Kerstin Stemmer; Wolfgang Wurst; Jan Rozman; Ruben Nogueiras; Meri De Angelis; Jeffery D Molkentin; Natalie Krahmer; Chun-Xia Yi; Mathias V Schmidt; Serge Luquet; Martin Heni; Matthias H Tschöp; Paul T Pfluger
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

10.  Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1.

Authors:  Lang Jiang; Lingyun Ren; Xin Guo; Jing Zhao; Hao Zhang; Shanshan Chen; Sheng Le; Hao Liu; Ping Ye; Manhua Chen; Jiahong Xia
Journal:  Int J Biol Sci       Date:  2021-05-27       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.